Concepedia
Statistics
Publications
14
Citations
891
H-Index
13
Active since
1987
Affiliations
Novartis (Switzerland)(Current)
Novartis (United States)
Tris Pharma (United States)
The University of Tokyo
Tsu‐Han Lin is an author at Novartis (Switzerland) specializing in pharmacology, pharmacy, and pharmacokinetics.
Publications per year
1987–2017
Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual‐Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi)
Jessie Gu, Adele Noè, Priya Chandra et al. · The Journal of Clinical Pharmacology · 2009 · 502 citations
Medicine, Pharmacokinetics, Pharmacology +17
Case Studies for Practical Food Effect Assessments across BCS/BDDCS Class Compounds using In Silico, In Vitro, and Preclinical In Vivo Data
Tycho Heimbach, Binfeng Xia, Tsu‐Han Lin et al. · The AAPS Journal · 2012 · 54 citations
Agriculture, Food Science, Toxicology +15
Nilotinib preclinical pharmacokinetics and practical application toward clinical projections of oral absorption and systemic availability
Binfeng Xia, Tycho Heimbach, Handan He et al. · Biopharmaceutics & Drug Disposition · 2012 · 47 citations
Pharmacy, Pharmacokinetics, Pharmacology +14
9cUAB30, an RXR specific retinoid, and/or tamoxifen in the prevention of methylnitrosourea-induced mammary cancers
Clinton J. Grubbs, Donald L. Hill, Kirby I. Bland et al. · Cancer Letters · 2003 · 42 citations
Medicine, Oncology, Pharmacology +16
‘Albumin-mediated transport phenomenon’ observed for ligands with high membrane permeability
Makoto Ichikawa, Su Chin Tsao, Tsu‐Han Lin et al. · Journal of Hepatology · 1992 · 41 citations
Engineering, Biochemistry, Biophysics +13
1–5 of 14